Focus on (foam) sclerotherapy of hemorrhoidal disease<\/p>\n\n\n\n
First international expert meeting at Kreussler's headquarter in Wiesbaden<\/p>\n\n\n\n
Sclerotherapy with liquid Aethoxysklerol has been used successfully for the treatment of hemorrhoidal disease since 1966. Whereas foam sclerotherapy has been proved as an effective treatment option for varicose veins for years, it was as late as 2006 when first studies in the treatment of hemorrhoidal disease with foam were started in ltaly and Germany. However, the ltalian method using a flexible endoscope turned out to be too complex and cost-intensive. The method using a proctoscope that has been developed by Dr. Moser from Germany, was picked up in ltaly only in 2015 and then further evaluated in several clinical studies. The latter ltalian activity caused a real boom in sclerotherapy.<\/p>\n\n\n\n
For\u00a0 this\u00a0 reason\u00a0 Kreussler\u00a0 Pharma,\u00a0 as\u00a0 the\u00a0 world's\u00a0 leading\u00a0 manufacturer\u00a0 of sclerosants, has initiated this first meeting focusing on hemorrhoidal disease with key opinion leaders from Germany, ltaly, and Poland. The aim of the meeting was to find a consensus on the most important issues in the field of sclerotherapy. On the 18th of January 2020, in the conference rooms of Kreussler, the experts discussed and\u00a0 summarized\u00a0 essential\u00a0 diagnostic\u00a0 measures\u00a0 and\u00a0 the\u00a0 best\u00a0 sclerotherapy techniques. In the afternoon, the experts introduced their experiences with foam<\/p>\n\n\n\n